October 25, 2016 11:58 PM ET


Company Overview of Sarepta Therapeutics, Inc.

Executive Profile

Richard Jon Barry

Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee, Sarepta Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 4 different industries.

See Board Relationships


Mr. Richard Jon Barry, also known as Rick, Founded Eastbourne Capital Management, L.L.C. Mr. Barry has been a Partner and Advisory Board member of the San Diego Padres since 2009 and an Advisory Board Member for the Schreyer Honors College at Pennsylvania State University since 2014. He is a Managing Member of GSM Fund, LLC. Mr. Barry served as Managing General Partner, Managing Member and Portfolio Manager at Eastbourne Capital Management, L.L.C. from 1999 to its close ...

Corporate Headquarters

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-274-4000
Fax: --

Board Members Memberships

Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee


Pennsylvania State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$37,099
Total Calculated Compensation$217,719

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


Stanley T. Crooke M.D., Ph.D.Founder, Executive Chairman, Chief Executive Officer, President, Chairman of Science/Medical Committee and Chairman of Agenda Committee
Ionis Pharmaceuticals, Inc.
John M. Maraganore M.D., Ph.D.Chief Executive Officer and Executive Director
Alnylam Pharmaceuticals, Inc.
Mark Joseph Murray Ph.D.Chief Executive Officer, President and Executive Director
Arbutus Biopharma Corporation
Paul C. Grint M.D.Chief Executive Officer, President and Director
Regulus Therapeutics Inc.
Douglas M. Fambrough III, Ph.D.Co-Founder, Chief Executive Officer, President and Director
Dicerna Pharmaceuticals, Inc.
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sarepta Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.